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been described [5]. Given the widespread use of these two 
drugs, this pharmacological interaction should be taken into 
account after an intracranial FD implantation.
Case Report
A 53-year-old man was referred to us because of an inci-
dental, large, wide neck and partially thrombosed saccular 
aneurysm of the proximal basilar trunk. The evaluation and 
comparison of magnetic resonance imaging (MRI) findings 
showed an increase in diameter of the aneurysm within 7 
months and a moderate mass effect on the brain stem. The 
largest axial diameter at the time of endovascular treatment 
was 27 mm (Fig. 1). As seen in the angiography prior to the 
treatment, the origin of the right anterior inferior cerebellar 
artery (AICA) was integrated in the aneurysm sac (Fig. 2).
Treatment
The treatment started with the surgical placement of a 
ventriculo-peritoneal shunt to prevent a potential cerebro-
spinal fluid circulation disturbance. Seven days later, the 
basilar artery was reconstructed through a combination of 
a conventional stent (Enterprise2, 4/39 mm, Codman Neu-
rovascular) and two FDs (p64, 2 × 4/24 mm, Phenox). The 
Enterprise2 stent was used as a scaffold to provide support 
for the flow modulating implants. Additionally, five coils 
were implanted in the caudal compartment of the aneurys-
mal sac (Fig. 3) to enhance the flow diverting effect of the 
two p64. Immediately prior to the intervention the patient 
received a loading dose of 500 mg ASA and 180 mg ticagre-
lor per os. Platelet function inhibition was confirmed before 
the treatment (Multiplate Test), being the values (AUC) 
adequately under the response threshold. The treatment was 
Introduction
The use of flow diverters (FD) became well established for 
the treatment of fusiform and selected sidewall intracranial 
aneurysms [1]. Even though flow diversion is relatively safe 
and efficacious, it is not without potential complications. 
They include ischemic and hemorrhagic events [2]. One of 
the critical aspects of this technique is the required pre- and 
postprocedural dual platelet function inhibition. The post-
procedural medication protocol following a FD implantation 
has two main goals: achieving an adequate level of platelet 
activity inhibition and reducing the inflammatory reaction in 
the aneurysmal wall [3, 4]. Therefore, we included in our 
protocol the dual antiplatelet therapy (in this case aspirin and 
ticagrelor) combined with ibuprofen and steroids to miti-
gate thrombus-related inflammation. A potential interference 
of ibuprofen with the antiaggregation effect of aspirin has 
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performed under anticoagulation (3000 units of heparin IV) 
and to ensure a correct platelet inhibition, a body weight 
adapted bolus of 15.8 mg eptifibatide was given. To prevent 
perianeurysmal edema and excessive inflammation, 40 mg 
of dexamethasone were given intravenously at the end of 
the procedure. Our postprocedural medication protocol of 
dual antiaggregation (100 mg ASA and 2 × 90 mg ticagre-
lor, both daily) is combined with steroid therapy for 3 days 
(3 × 4 mg dexamethasone daily) and 1 × 400 mg ibuprofen 
daily for 3 weeks (per os, taken at least 2 h after ASA).
Outcome, Follow-up
The MRI/MRA before discharge confirmed patency of the 
vertebral and basilar arteries, including the right AICA, and 
thrombosis of the aneurysmal sac (Fig. 4).
Fig. 4 Time-of-flight magnetic resonance angiography (TOF-MRA) 
3 days later confirms the patency of the basilar artery and the right 
anterior inferior cerebellar artery (AICA)
 
Fig. 3 Digital subtraction angiography (DSA) image after partial coil 
occlusion and reconstruction of the parent vessel with an Enterprise2 
stent and two p64 flow diverters
 
Fig. 2 Digital subtraction angiography (DSA) image of the aneurysm, 
showing the very wide neck of the aneurysm. The right anterior infe-
rior cerebellar artery (AICA) is integrated in the aneurismal sac
 
Fig. 1 T2-weighted axial magnetic resonance imaging (MRI) of a 
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artery and facilitate the development of a neointimal layer 
[6]. This structure could be a combination of conventional 
stents and/or FDs, coaxially implanted and covering the 
pathologic segment of the basilar trunk.
An accumulating body of evidence implicates inflam-
mation as a critical contributor to aneurysm formation, 
progression and eventual rupture [7, 8]. The ESMINT Ret-
rospective Analysis of Delayed Aneurysm Ruptures after 
Flow Diversion (RADAR) showed that the vast majority 
of the aneurysms with delayed rupture were very large or 
giant (mean diameter of 24 mm) [9]. Another alarm sign 
could be recent growth, indicating instability of the aneu-
rysm wall. Both, large size and recent growth were pres-
ent in our patient. It is described that the acute formation 
of massive clot inside an aneurysm after flow diversion can 
act as a trigger for aggressive inflammatory processes in the 
aneurysmal wall, leading to a complete degeneration of the 
wall and consequently causing delayed rupture in approxi-
mately 1–2 % of cases [3, 4, 9]. The rapid blood clot forma-
tion inside an aneurysm after FD implantation would be the 
One week later the patient collapsed at home. He experi-
enced progressive coma during an extended transfer to our 
facility. A MRI examination upon arrival revealed complete 
occlusion of the basilar artery. The family confirmed that all 
prescribed medication had been taken; however, aspirin and 
ibuprofen were taken together. A Multiplate test revealed 
that there was no aspirin effect on the thrombocytic func-
tion. An analysis of urine and venous blood confirmed the 
presence of ibuprofen in both. An aspiration thrombectomy 
was immediately performed, and the basilar artery was suc-
cessfully recanalized (Fig. 5a, b). On MRI, extensive isch-
emic damage of the pons and the right AICA territory was 
found post thrombectomy (Fig. 6). Increasing edema and 
tonsillar herniation resulted in death 4 days later due to car-
diorespiratory arrest.
Discussion
Aneurysms of the basilar artery are rare. Basilar trunk aneu-
rysms are classified as segmental ectasia without intralumi-
nal thrombus or as dissecting aneurysms with widespread 
disruption of the elastic lamina, thickened intima and exten-
sive intraluminal thrombus [6]. Some of these segmental 
diseases result in aneurysms with a predominant saccular 
component, as in our case. These aneurysms of the basi-
lar trunk, if left untreated, have poor survival rates. Patients 
suffer from progressive brain stem compression or sub-
arachnoid hemorrhage, or both.
Reconstructive treatment of wide neck and fusiform 
vertebrobasilar aneurysms has been facilitated with the 
advent of FDs. The prognostic impact of a reconstructive 
endovascular treatment of large and giant dolichoectatic 
and dissecting vertebrobasilar aneurysms remains difficult 
to determine, but given the poor prognosis, treatment should 
be considered in symptomatic patients and in growing aneu-
rysms. The goal of the procedure described above would not 
only be exclusion of the aneurysm from the normal blood 
circulation, but also to provide a structural support for the 
Fig. 6 Subsequent magnetic resonance imaging (MRI), however, 
showed massive brain stem infarction
 
Fig. 5 Digital subtraction angi-
ography (DSA) 1 week later con-
firms acute thrombotic occlusion 
of the flow diverters (a), which 




358 R. Martinez-Moreno et al.
stents or alone is feasible in many cases. In large or giant 
aneurysms, the use of coils to stabilize the clot formation 
is recommended. The postprocedural combination of dual 
antiplatelet medication with anti-inflammatory agents such 
as steroids and selective COX-2 inhibitors is also needed. 
The combination of aspirin and nonselective NSAIDs such 
as ibuprofen or naproxen must be avoided.
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key factor in the overwhelming of the defense mechanism 
of vessel remodeling against autolytic activities. Histo-
pathologically this clot has been identified as a disorganized 
thrombus without significant cellular colonization. On the 
other hand, the intraaneurysmal thrombosis induced by plat-
inum and tungsten coils has demonstrated to promote the 
formation of a granulation tissue with capillary in growth as 
well as the proliferation and progressive replacement of the 
blood clot with increasingly collagenized fibrous scar tissue 
[10]. Therefore, a combined strategy of flow diversion and 
partial coil-occlusion of the aneurysmal sac may be used in 
order to stimulate a stable thrombosis of the aneurysm.
The second part of the strategy to control the inflamma-
tory processes in the aneurysm sac includes the combination 
of dual antiplatelet medication (aspirin and clopidogrel or 
ticagrelor) with an additional nonsteroidal anti-inflammatory 
drug (NSAID) and steroids immediately after the intervention.
The interaction of various groups of NSAIDs with the 
thrombocyte inhibitory effect of aspirin has been relatively 
well described in the past, and recently analyzed in a pla-
cebo-controlled, ex vivo, serial placebo-controlled crossover 
study, among others [5, 11]. Inflammatory processes leading 
to nociceptive pain and thrombocyte aggregation are both 
mediated by different isoforms of the same enzyme, the 
cyclooxygenase (COX). COX-1 plays a major role in throm-
bocyte aggregation; COX-2 participates in the inflamma-
tory response to tissue damage. In this study ibuprofen and 
naproxen, nonselective agents with an inherent weak throm-
bocyte inhibitory action, inhibit aspirin’s antiaggregant effect 
significantly, whereas the COX-2 selective NSAIDs meloxi-
cam and etoricoxib caused no significant aspirin inhibition.
The effect of Ibuprofen administration in patients under 
aspirin therapy was also well described in a publication from 
Catella-Lawson et al. [11, 12]. According to their results Ibupro-
fen might competitively bloc the inhibition of platelet COX-1 
activity achieved by ASA. However, a single dose of Ibupro-
fen given 2 h after the administration of ASA could avoid this 
interaction. The authors warn, otherwise, that in a second study 
simulating a more clinically relevant ibuprofen dosage regimen 
(three times daily) the time gap of 2 h between the ASA and 
Ibuprofen morning doses failed to bypass the interaction.
Our case illustrates the potentially dramatic conse-
quences of this pharmacological interaction and forces one 
to have these results in mind to avoid fatal thromboembolic 
complications in the future.
Conclusion
Given their poor prognosis, the symptomatic, wide neck 
or fusiform, dolichoectatic or dissecting, vertebrobasilar 
aneurysms should be treated. A reconstructive endovascu-
lar therapy with FDs either combined with conventional 
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